| Abstrakt: |
A study conducted at the Medical University of Graz in Austria explored the association between the Charlson-Deyo Comorbidity Index (CCI) and the recurrence of non-muscle-invasive bladder cancer (NMIBC). The study analyzed data from 1,072 NMIBC patients who underwent transurethral resection of bladder tumor (TURB) between 2010 and 2018. The findings showed that patients with a higher comorbidity burden, as indicated by a higher CCI, had an increased risk of bladder cancer recurrence. The researchers recommend that patients with a high comorbidity burden adhere to NMIBC guidelines and follow-up protocols. [Extracted from the article] |
